06-24
→
Jilin Haotai Health Industry Development Co., Ltd. participated in the 23rd World Pharmaceutical Raw Materials China Exhibition. On the first day of the exhibition, it received a total of 27 well-known brand enterprises and more than 6,000 visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the UK, Germany, France, Belgium, Italy, Switzerland, Spain and other countries.
06-24
→
Jilin Haotai Health Industry Development Co., Ltd. is exhibiting at the 23rd China International Pharmaceutical Ingredients Exhibition. On the first day of the exhibition, the company welcomed a total of 27 well-known brand enterprises and over 6,000 visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the United Kingdom, Germany, France, Belgium, Italy, Switzerland, and Spain.
03-04
→
Recently, the Jilin Equity Exchange officially released the list of “Specialized, Fine, and New” enterprises for 2024 in Jilin Province. Jilin Haotai Health Industry Development Co., Ltd. has successfully been included on this list thanks to its professional expertise and innovative strengths in the health sector, becoming one of the 52 companies featured. The company’s dedicated board code on the Jilin Exchange is 810016.
11-15
→
On November 2, 2024, to celebrate the company’s second anniversary, our organization arranged a series of unique team-building activities aimed at strengthening team cohesion and fostering better communication and interaction among employees. At noon, we all headed to Wanda Cinemas to watch the movie “The Battle for Survival of the Volunteer Army.” The film’s portrayal of the heroes’ resilience and spirit of sacrifice deeply touched each of us, igniting everyone’s patriotic enthusiasm and sense of teamwork.
08-26
→
We have received the listing application documents submitted by your company through Jilin Xinda HuiBao Investment Consulting Co., Ltd. After review, we hereby approve your company’s entry into our transfer board for listing. The company’s abbreviated name is Haotai Health, and its listing code is 520023. Please carry out all listing-related tasks in accordance with applicable regulations.
08-26
→Introduction to Haotai Health Jisheng Products and Services
The pharmaceutical intermediate and active pharmaceutical ingredient (API) project is a wholly-owned subsidiary of Haotai Health. The project is located in the industrial park at No. 639 Changlong Avenue, Chaoyang Town, Huinan County, Tonghua City, Jilin Province. The factory covers an area of approximately 32,920.00 square meters, with a total construction area of about 14,088.34 square meters. The facility includes one office building, two laboratory buildings, one industrial building, and seven ancillary structures, as well as more than 300 pieces of equipment.
08-26
→
Congratulations Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd. officially opened its website. Our company is engaged in the biomedical health industry and is a diversified technology company integrating R & D, production and sales. The company has achieved 15 scientific and technological achievements transformation, the average annual transformation of 5. It has 10 intellectual property rights within the validity period, including 8 invention patents, 2 utility model patents and 7 novelty search reports. 5 registered trademarks and 1 copyright.